NASDAQ: IMMP       Immutep Ltd ADR
Last Price Today's Change   Day's Range   Trading Volume
3.18   -0.14 (4.22%)  3.05 - 3.35  533,996


Avg Volume (4 weeks):1,280,394
4 Weeks Range:2.77 - 3.633
4 Weeks Price Volatility (%):
52 Weeks Range:0.53 - 7.95
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Prima BioMed Ltd is a globally active biotechnology company developing immunotherapeutic products for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives most of the revenue from the sale of the products.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3725  2588  331  3248 

Top 10 Active Counters
 ADMP 1.83+0.56 
 CTRM 0.397-0.028 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 AZRX 2.109+0.869 
 SNDL 0.631-0.031 
 NIO 60.925+2.585 
 BNGO 9.44+1.17 
 F 11.368-0.162 
 OBLN 6.17+0.98